NCT00625417View on ClinicalTrials.gov

Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Breast Cancer
Interventions
PROCEDURE

breast biopsy

PROCEDURE

histopathologic examination

PROCEDURE

light-scattering spectroscopy

PROCEDURE

therapeutic conventional surgery

Trial Locations (3)

37064

Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville

Vanderbilt-Ingram Cancer Center at Franklin, Nashville

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt University

OTHER

NCT00625417 - Optical Spectroscopy in Evaluating Tumor Margins in Patients Who Have Undergone Surgery for Breast Tumors | Biotech Hunter | Biotech Hunter